
CAS 1176637-26-5
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
2 produits concernés.
(Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]-N,N-diethylhept-5-enamide
CAS :Produit contrôlé<p>7-[(E)-3-hydroxy-5-(1H-pyrrol-2-yl)pent-1-enyl]-N,N-diethylheptanamide (HEPA) is a ligand that binds to the β2 adrenergic receptor. HEPA has been shown to be an inhibitor of ion channels and an activator of G protein coupled receptors. The antibody recognizes the peptide sequence VEEEPQGKKPGSSYKDVEVR. This product is for research purposes only and should not be used as a medical treatment.</p>Formule :C27H41NO4Degré de pureté :Min. 95%Masse moléculaire :443.6 g/mol17-phenyl trinor Prostaglandin F2α diethyl amide
CAS :<p>17-Phenyl trinor Prostaglandin F2αdiethyl amide (17-phenyl trinor PGF2αdiethyl amide) is a Prostaglandin F2α(PGF2α) analog characterized by the substitution of the C-1 carboxyl group with an N-diethyl amide. Prostaglandin (PG) esters and N-ethyl amides have demonstrated ocular hypotensive properties, with N-ethyl amides introduced as alternative options for PG hypotensive prodrugs. Studies indicate that both bovine and human corneal tissues can convert N-ethyl amides of various PGs into their free acid forms at a rate of approximately 2.5 µg/g corneal tissue/hr. However, dialkyl amides like 17-phenyl trinor PGF2αdiethyl amide resist conversion by corneal amidase, showing no detectable transformation into free acids. This characteristic suggests their potential as valuable investigative tools for assessing the intrinsic intraocular hypotensive activities of PG amides.</p>Formule :C27H41NO4Couleur et forme :SolidMasse moléculaire :443.6

